Watch for the Capital Allocation Committee's initial review results within three months — the company will announce a target capital structure and allocation framework, which could signal share buybacks, debt reduction, or M&A priorities. The 2026 Annual Meeting on December 10, 2026 will formalize Haggart's election and Guttentag's board appointment.
Price Chart
Executive Summary
Stride, Inc. entered into a cooperation agreement with activist investor Fivespan Partners, appointing Fivespan founder Dylan Haggart and education technology executive Dr. Steven Guttentag to the board. The company will form a new Capital Allocation Committee co-chaired by Haggart and independent director Brian Shepherd, with a mandate to review capital structure and allocation strategy and publicly announce a target framework within three months. Fivespan withdrew its proxy contest and Section 220 books-and-records demand in exchange for board seats, standstill restrictions, and expense reimbursement.
Key Facts
- Cooperation agreement dated October 8, 2026 between Stride and Fivespan Partners.
- Dylan Haggart (Fivespan founder) appointed to board effective October 30, 2026, and nominated for election at the 2026 Annual Meeting.
- Dr. Steven Guttentag appointed as non-voting board observer immediately, to become a director after the 2026 Annual Meeting.
- Board size to increase from 8 to 10 directors after the 2026 Annual Meeting.
- New Capital Allocation Committee formed, co-chaired by Brian Shepherd and Dylan Haggart, with CEO Robert Knowling as non-voting member.
- Company to publicly announce target capital structure and capital allocation framework within three months.
- Fivespan agreed to a standstill (ownership cap 7.5% beneficial, 12.5% economic exposure) and voting commitments through the 2027 Annual Meeting cycle.
- Fivespan withdrew its September 1, 2026 director nominations, shareholder proposal, and Section 220 demand.
- Company to reimburse Fivespan's out-of-pocket expenses subject to a confidential cap.
- Director Allison Lawrence resigned effective immediately prior to Haggart's appointment, will serve as non-voting observer then be re-appointed after the 2026 Annual Meeting.
Financial Impact
No financial figures disclosed. Expense reimbursement to Fivespan subject to an undisclosed cap. Capital allocation review expected within 3 months.
Risk Factors
- Standstill period ends 30 days before the 2027 Annual Meeting nomination deadline, potentially reopening activist pressure.
- Capital allocation framework may disappoint if it does not include aggressive buybacks or leverage increases.
- Fivespan's 7.5% beneficial ownership cap limits further accumulation, reducing potential for a full sale push.
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-114863 |
| Document: tm2627338d1_8k.htm | 0001104659-26-114863 |
| Document: tm2627338d1_ex99-1.htm | 0001104659-26-114863 |
| Document: 0001104659-26-114863-index-headers.html | 0001104659-26-114863 |
| Document: 0001104659-26-114863-index.html | 0001104659-26-114863 |
| Document: 0001104659-26-114863.txt | 0001104659-26-114863 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | DEF 14A / DEFA14A | $78.04 | awaiting T+5 | — | $79.21 (+1.50%) |
Oct 20, 2026 7d ago | 8-K | $76.39 | awaiting T+5 | — | $79.21 (+3.69%) |
Oct 20, 2026 7d ago | Press Release | $76.39 | awaiting T+5 | — | $79.21 (+3.69%) |
Oct 9, 2026 18d ago | 8-K | $85.59 $82.39 | ▼ −3.74% | ▼ −1.77% | $79.21 (−7.45%) |
Oct 8, 2026 19d ago | SC 13G | $81.36 $83.18 | ▲ +2.24% | ▲ +2.51% | $79.21 (−2.64%) |
Jul 30, 2026 12w ago | 8-K | $83.07 $80.00 | ▼ −3.70% | ▼ −7.32% | $79.21 (−4.65%) |
Jul 21, 2026 14w ago | Press Release | $84.22 $97.71 | ▲ +16.02% | ▲ +18.42% | $79.21 (−5.95%) |
Mar 10, 2026 33w ago | Press Release | $84.60 $87.08 | ▲ +2.93% | ▲ +3.84% | $79.21 (−6.37%) |
Mar 9, 2026 33w ago | Press Release | $85.31 $82.97 | ▼ −2.74% | ▼ −1.39% | $79.21 (−7.15%) |
Mar 9, 2026 33w ago | Press Release | $85.31 $82.97 | ▼ −2.74% | ▼ −1.39% | $79.21 (−7.15%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers